financial post
RAMM Pharma Corp. Receives Minority Shareholder Approval for Proposed Investment Transaction with The Global South S.A.S.
Financial Post • 4 MONTHS AGO
Stantec reports strong third quarter 2025 results, delivering over 17% growth in adjusted earnings per share
Financial Post • 4 MONTHS AGO
Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstrating Consistent Results after Dosing with EP-104GI
Financial Post • 4 MONTHS AGO
Peyto Reports Third Quarter Results and Preliminary 2026 Capital Program
Financial Post • 4 MONTHS AGO
DPM Metals Reports Record Third Quarter 2025 Financial Results; Vareš Positioned for Significant Value Creation
Financial Post • 4 MONTHS AGO
Brookfield Asset Management Announces Pricing of $600 Million Notes Due 2030 and $400 Million Notes Due 2036
Financial Post • 4 MONTHS AGO